OssiFi

Ossifi email format

Verified email-pattern data for Ossifi is currently limited. You can still use the company insights and contact sections below.
OssiFi Therapeutics is developing market disruptive anti-sclerostin regenerative bone-biology products to address significant unmet needs in low back pain, fracture repair, and fracture prevention. OssiFi's Key value drivers: 1) Oral competitor to Amgen’s injectable anti-sclerostin mAb product (Evenity®), and 2) Anti-sclerostin small molecule competitor to Medtronic’s INFUSE orthobiologic. OssiFi is seeking investor capital and strategic partnerships to support its efforts to deliver best-in-class bone regenerative therapies to prevent and treat fractures in patients suffering from Osteogenesis Imperfecta, post-menopausal osteoporosis, and other fragile-bone disorders.
Looking for a particular OssiFi employee's phone or email?

Ossifi Questions

Explore related pages

Related company profiles:

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant